Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/44977
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | CUPPENS, Kristof | - |
dc.contributor.author | Baas, P. | - |
dc.contributor.author | Wiesweg, M. | - |
dc.contributor.author | Du Pont, B. | - |
dc.contributor.author | Ploenes, T. | - |
dc.contributor.author | Theegarten, D. | - |
dc.contributor.author | Aigner, C. | - |
dc.contributor.author | Hartemink, K. | - |
dc.contributor.author | MAES, Brigitte | - |
dc.contributor.author | Pat, K. | - |
dc.contributor.author | Schuler, M. | - |
dc.date.accessioned | 2025-01-07T09:40:51Z | - |
dc.date.available | 2025-01-07T09:40:51Z | - |
dc.date.issued | 2024 | - |
dc.date.submitted | 2025-01-03T11:41:00Z | - |
dc.identifier.citation | Journal of thoracic oncology, 19 (10) , p. S9 | - |
dc.identifier.uri | http://hdl.handle.net/1942/44977 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject.other | neoadjuvant | - |
dc.subject.other | LAG-3 | - |
dc.subject.other | relatlimab | - |
dc.title | Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up | - |
dc.type | Journal Contribution | - |
dc.identifier.issue | 10 | - |
dc.identifier.spage | S9 | - |
dc.identifier.volume | 19 | - |
local.format.pages | 1 | - |
local.bibliographicCitation.jcat | M | - |
local.publisher.place | STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.identifier.isi | 001337925600014 | - |
local.provider.type | wosris | - |
local.description.affiliation | [Cuppens, K.; Du Pont, B.; Maes, B.; Pat, K.] Jessa Hosp, Hasselt, Belgium. | - |
local.description.affiliation | [Baas, P.; Hartemink, K.] Netherlands Canc Inst, Amsterdam, Netherlands. | - |
local.description.affiliation | [Wiesweg, M.; Theegarten, D.; Schuler, M.] Univ Hosp Essen, Essen, Germany. | - |
local.description.affiliation | [Ploenes, T.] Univ Med Essen, Ruhrlandklin, Essen, Germany. | - |
local.description.affiliation | [Aigner, C.] Med Univ Vienna, Vienna, Austria. | - |
local.uhasselt.international | yes | - |
item.fulltext | No Fulltext | - |
item.contributor | CUPPENS, Kristof | - |
item.contributor | Baas, P. | - |
item.contributor | Wiesweg, M. | - |
item.contributor | Du Pont, B. | - |
item.contributor | Ploenes, T. | - |
item.contributor | Theegarten, D. | - |
item.contributor | Aigner, C. | - |
item.contributor | Hartemink, K. | - |
item.contributor | MAES, Brigitte | - |
item.contributor | Pat, K. | - |
item.contributor | Schuler, M. | - |
item.fullcitation | CUPPENS, Kristof; Baas, P.; Wiesweg, M.; Du Pont, B.; Ploenes, T.; Theegarten, D.; Aigner, C.; Hartemink, K.; MAES, Brigitte; Pat, K. & Schuler, M. (2024) Neoadjuvant Nivolumab with or without Relatlimab in Resectable NSCLC: Additional Analysis and Extended Follow-up. In: Journal of thoracic oncology, 19 (10) , p. S9. | - |
item.accessRights | Closed Access | - |
crisitem.journal.issn | 1556-0864 | - |
crisitem.journal.eissn | 1556-1380 | - |
Appears in Collections: | Research publications |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.